Cost of Capital Essay Example | Topics and Well Written Essays - 500 words - 3

Cost of Capital - Essay Examplels as far conniving the actual cost of capital of Pfizer, but it does point out that Pfizer has more equity than debt because the secures prefers to keep its fill payments low in order to maintain good liquidity and change flows. Pfizer operates in industry that has actually high risk. Every year hundreds of forward-looking medicines project fail for a variety of reasons. Sometimes these medicines do not work as the company expected or even when they work the new medicine often is not adequate to(p) to comply with the strict protocols to achieve FDA approval. Whenever a medicine is not able to reach food market the total costs that the pharmaceutical company incurred in becomes a sunk cost. A sunk cost can be defined as a cost that cannot be changed by any present or future decision (Weygandt, Kieso, Kimmel, 2002). Sunk cost be a major(ip) financial challenge for companies such as Pfizer. Minimizing projects that do not provide a positive bu rgeon forth of cash flows is imperative for the success of a company in the pharmaceutical industry.Pfizer faces other financial challenges that are unique to its industry. For instance the company has to invest billions of dollars each year in research and development costs. The fairish out of pocket cost to develop a new drug is $1.4 billion (Mullin, 2014). Another financial challenge Pfizer faces is that it also takes a long time for a new drug to reach market. piece a new drug is being developed the company does not obtain any inflows of cash from that project. Despite the challenges associated with developing a new drug when a company succeeds in creating a new product the law protects firms such as Pfizer. Patent protection allows Pfizer the ability to create a monopoly market on the new drug. Patent protection in the pharmaceutical industry can last octonary to ten years. During that time Pfizer would face no competition for its new drug. Another challenge that Pfizer face s is a shortfall of talent in many technical fields. In order to recruit new talent the firm